APR 15, 2016 06:41 AM PDT

Study Reveals Gut Bacteria Delayed Onset of Cancers

WRITTEN BY: Xuan Pham
Good gut bacteria can promote a healthy immune system, which in turn, could reduce the risks for some types of cancers, say scientists at UCLA. The study, published in the journal PLOS ONE, finds that a common beneficial bacterial strain slowed the growth of lymphoma in mice through the production of anti-inflammatory metabolites.
 
Lactobacillus johnsonii has anti-inflammatory properties that could reduce cancer risks
The microbiome is a specialized collection of bacteria residing in the human body. Bacterial cells outnumber human cells ten to one: there are about 10 trillion bacteria compared to the 1 trillion human cells in the body. Mostly famous for their existence in the human gut, these communities of microorganisms have been known to influence processes like digestion and immune responses. In some cases, the bacteria can be harmful and have been linked to obesity, stomach cancer, and even male reproductive disorders. However, some collection of bacteria can actually promote health and wellness through their anti-inflammatory properties.
 
In their study, the UCLA team, led by Robert Schiestl, honed in on a specific strain of bacteria known as Lactobacillus johnsonii. This is the most abundant strain of the so-called “good” bacteria in our system, as it has been shown to reduce inflammation and DNA damage. The team also focused on mice genetically engineered to have mutations in ATM – DNA repair gene, which results in a neurologic disorder called ataxia telangiectasia (AT). A high incidence of cancers, such as leukemia and lymphomas, are associated with AT.
 
Separated into two groups, the team exposed one group to only the anti-inflammatory Lactobacillus bacteria, and the other group received mixture of microbes that normally exist in the intestines, including both good and bad bacteria.
 
They found mice with more anti-inflammatory Lactobacillus bacteria had delayed onset of lymphomas. This was published in a previous report in Cancer Research. In the current study, the team found additional evidence for the anti-cancer effects of the Lactobacillus bacteria. Specifically, mice exposed only to Lactobacillus produced metabolites known to protect against cancer, including 3-methylbutyrolactone, kyneurenic acid and 3-methyladenine.
 
The beneficial microbiota also had a role in prolong survival of the mice – they lived four times longer than those that received a mixture of bacteria, and showed less DNA damage overall.
 
 
The results provide good news for health experts and patients all around, as it suggests modulating the amount of good bacteria in your gut could actually have a positive effect on cancer risks. "Since it is a Lactobacillus strain, it makes excellent yogurt, kefir, kombucha and sauerkraut,” Schiestl commented.
 
Ultimately, the team sees chemotherapeutic potential in anti-inflammatory probiotics, which can easily be administered. "It is not invasive and rather easy to do," Schiestl said. “In the future, it is our hope that the use of probiotics-containing [supplements] would be a potential chemopreventive for normal humans, while the same type of microbiota would decrease tumor incidence in cancer susceptible populations."

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 14, 2018
Cancer
NOV 14, 2018
How Cancer's 'Invisibility Cloak' Works
One of cancer’s cunning strategies to evade death is to make itself invisible to the immune system. Now researchers say they’ve identified the...
JUL 17, 2018
Cancer
JUL 17, 2018
Large Multifactorial NIH Study Announced for Prostate Cancer Aggressiveness in African-American Men
The largest coordinated study on Prostate cancer aims to look at both genetic and environmental factors that lead to increased risk and cancer aggressiveness in African-American men compared...
JUL 17, 2018
Cancer
JUL 17, 2018
Immunotherapy Diversification: From CAR-T cells to CAR-NK cells
New advances have made it possible for immunotherapy researchers to use natural killer cells, which are our body's normal defense for cancerous cells, to target tumors....
SEP 14, 2018
Health & Medicine
SEP 14, 2018
Can You Get Addicted to Tanning at the Gym?
Do you know what GTL means? If you're a fan of the reality series "The Jersey Shore" then you know it stands for "Gym, Tan, Laundry"...
OCT 29, 2018
Neuroscience
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
NOV 24, 2018
Drug Discovery
NOV 24, 2018
New Anti-Malarial Drug Target in Cancer
For decades, anti-malaria drugs--known as Chloroquines, have used to treat cancer. But the role in repurposing these drugs for slowing tumor growth have ne...
Loading Comments...